Search research articles
Contact Us
Filters
Showing results (11-20 of 72) with videos related to
Page
of 8
Sort By:
Scientific Reports
|
September 10, 2021
DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis
Anna Chashchina, Melanie Märklin, Clemens Hinterleitner, et al.
Pathology Oncology Research : POR
|
August 29, 2025
B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatment
Julia M Ott, Verena Gassenmaier, Michael Bitzer, et al.
Viruses
|
March 30, 2023
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
Christopher Hackenbruch, Yacine Maringer, Christian M Tegeler, et al.
Pharmaceutical Statistics
|
October 26, 2022
Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage
Jannik Labrenz, Dominic Edelmann, Jonas S Heitmann, et al.
Leukemia & Lymphoma
|
June 17, 2020
Fc gamma receptor expression serves as prognostic and diagnostic factor in AML
Jonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, et al.
BMJ Open
|
October 17, 2020
Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma
Jonas S Heitmann, Juliane S Walz, Martin Pflügler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 16, 2022
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
Christian M Tegeler, Tatjana Bilich, Yacine Maringer, et al.
Cancers
|
July 12, 2020
HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
Malte Roerden, Annika Nelde, Jonas S Heitmann, et al.
Annals of Hematology
|
January 23, 2020
Identification of CD318 (CDCP1) as novel prognostic marker in AML
Jonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, et al.
Cancers
|
May 14, 2022
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients
Christian M Tegeler, Jonas Scheid, Hans-Georg Rammensee, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 72) with videos related to
Sort By:
Page
of 8
Scientific Reports
|
September 10, 2021
DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis
Anna Chashchina, Melanie Märklin, Clemens Hinterleitner, et al.
Pathology Oncology Research : POR
|
August 29, 2025
B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatment
Julia M Ott, Verena Gassenmaier, Michael Bitzer, et al.
Viruses
|
March 30, 2023
Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
Christopher Hackenbruch, Yacine Maringer, Christian M Tegeler, et al.
Pharmaceutical Statistics
|
October 26, 2022
Performance of phase-I dose finding designs with and without a run-in intra-patient dose escalation stage
Jannik Labrenz, Dominic Edelmann, Jonas S Heitmann, et al.
Leukemia & Lymphoma
|
June 17, 2020
Fc gamma receptor expression serves as prognostic and diagnostic factor in AML
Jonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, et al.
BMJ Open
|
October 17, 2020
Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma
Jonas S Heitmann, Juliane S Walz, Martin Pflügler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
April 16, 2022
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
Christian M Tegeler, Tatjana Bilich, Yacine Maringer, et al.
Cancers
|
July 12, 2020
HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
Malte Roerden, Annika Nelde, Jonas S Heitmann, et al.
Annals of Hematology
|
January 23, 2020
Identification of CD318 (CDCP1) as novel prognostic marker in AML
Jonas S Heitmann, Ilona Hagelstein, Clemens Hinterleitner, et al.
Cancers
|
May 14, 2022
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer Patients
Christian M Tegeler, Jonas Scheid, Hans-Georg Rammensee, et al.
Page
of 8